Ariane Bisaillon
Associate | Montréal
Montréal: 514-982-4137

Ariane's practice covers various aspects of civil and commercial law, with a particular focus on commercial litigation, class actions, product liability and consumer contracts. Her practice also covers shareholders' disputes, arbitration and extraordinary proceedings. She advises national and foreign clients, including pharmaceutical companies, manufacturers, banks, transportation companies, and local businesses.

Ariane is fluent in French and English and has a practical knowledge of Spanish.

SELECT EXPERIENCE

  • Currently defending the interests of a major international pharmaceutical company in three class actions respecting side effects allegedly caused by some of its products;

  • Currently defending a medical device manufacturer in a class action relating to alleged manufacturing and design devices defects;

  • Currently defending a major Canadian major airline company in a class action relating to alleged violations of the Consumer Protection Act;

  • Currently defending a bank in a series of class actions relating to alleged violations of the Consumer Protection Act;

  • Part of a team that successfully brought to an early discontinuance a class action brought against hip device manufacturer in connection with alleged manufacturing defects;

  • Part of a team that successfully obtained early termination of a class action brought against one of the largest software manufacturers;

  • Part of a team that successfully defended Coca-Cola in connection with alleged misrepresentations as to Vitaminwater® products;

  • Counsel to multinational corporations in class actions regarding consumer contracts and product liability for pharmaceuticals and other consumer products;
  • Advising a multinational corporation on compliance with Canadian trade regulations.
PUBLICATIONS
Show Past:
Page: 1 of 1       1        Items per page: 25 | 50 | ALL
Co-author: Expert Evidence in Canada: An Expert's Lack of Independence Could Lead to the Exclusion of Her Report DRI, RX for the Defense
The Newsletter of the Drug and Medical Device Committee, Volume 23, issue 3.
Blakes Bulletin on Securities Litigations/Class Actions, April 2015.
Page: 1 of 1       1        Items per page: 25 | 50 | ALL